Wikidata

(Q33380352)

English

Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma

scientific article

In more languages

Statements

title
Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin's lymphoma (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
18626004
retrieved
26 July 2017
author name string
K Sue Robinson
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
18626004
retrieved
26 July 2017
Michael E Williams
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
18626004
retrieved
26 July 2017
Richard H van der Jagt
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
18626004
retrieved
26 July 2017
Philip Cohen
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
18626004
retrieved
26 July 2017
Jordan A Herst
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
18626004
retrieved
26 July 2017
Anil Tulpule
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
18626004
retrieved
26 July 2017
Lee S Schwartzberg
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
18626004
retrieved
26 July 2017
Bernard Lemieux
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
18626004
retrieved
26 July 2017
page(s)
4473-4479
1 reference
stated in
Europe PubMed Central
PubMed ID
18626004
retrieved
26 July 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q33380352&oldid=1966552982"